Suppr超能文献

炎症在骨髓增殖性肿瘤中的关键作用:疾病起始、进展和症状的推动者。

Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms.

机构信息

Department of Biological Chemistry, University of California Irvine, 839 Medical Sciences Rd, Sprague Hall 126, Irvine, CA, 92617, USA.

Division of Hematology/Oncology, Department of Medicine, University of California Irvine, 839 Medical Sciences Rd, Sprague Hall 126, Irvine, CA, 92617, USA.

出版信息

Curr Hematol Malig Rep. 2019 Jun;14(3):145-153. doi: 10.1007/s11899-019-00508-w.

Abstract

PURPOSE OF REVIEW

Chronic inflammation is a characteristic feature of myeloproliferative neoplasm (MPN) and impacts many aspects of the disease including initiation, progression, and symptomatology.

RECENT FINDINGS

The chronic inflammatory state of MPN results from disruption of immune signaling pathways leading to overproduction of inflammatory cytokines by both the neoplastic clones and bystander immune cells. This chronic inflammation may allow for the neoplastic clone to gain a selective advantage. The symptomatic burden felt by MPN patients may be a result of the chronic inflammation associated with MPN, as several cytokines have been linked with different symptoms. Pharmacologic as well as nonpharmacologic treatments of the inflammatory component of this disease may lead to decreased symptomatic burden, prevention of disease progression, and improvement in overall disease trajectory. Inflammation plays a key role in the pathogenesis of MPN and represents an important therapeutic target.

摘要

目的综述

慢性炎症是骨髓增殖性肿瘤(MPN)的特征之一,影响疾病的许多方面,包括发病、进展和症状学。

最新发现

MPN 的慢性炎症状态源于免疫信号通路的破坏,导致肿瘤克隆和旁观者免疫细胞过度产生炎性细胞因子。这种慢性炎症可能使肿瘤克隆获得选择性优势。MPN 患者的症状负担可能是与 MPN 相关的慢性炎症的结果,因为几种细胞因子与不同的症状有关。这种疾病炎症成分的药物和非药物治疗可能会减轻症状负担,预防疾病进展,并改善整体疾病轨迹。炎症在 MPN 的发病机制中起关键作用,是一个重要的治疗靶点。

相似文献

4
Inflammation and myeloproliferative neoplasms.炎症和骨髓增殖性肿瘤。
J Autoimmun. 2017 Dec;85:58-63. doi: 10.1016/j.jaut.2017.06.010. Epub 2017 Jun 30.
5
The Rationale for Immunotherapy in Myeloproliferative Neoplasms.骨髓增殖性肿瘤免疫治疗的理论依据。
Curr Hematol Malig Rep. 2019 Aug;14(4):310-327. doi: 10.1007/s11899-019-00527-7.
6

引用本文的文献

9
Metformin for MPN: teaching an old drug new tricks.二甲双胍用于骨髓增殖性肿瘤:让老药发挥新作用
Blood Adv. 2024 Aug 27;8(16):4476-4477. doi: 10.1182/bloodadvances.2024013429.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验